Compare SSTI & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSTI | SERA |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | United States | United States |
| Employees | 305 | N/A |
| Industry | Computer Software: Prepackaged Software | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.8M | 75.2M |
| IPO Year | 2017 | 2021 |
| Metric | SSTI | SERA |
|---|---|---|
| Price | $6.80 | $2.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 86.5K | 39.3K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.32 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $34,753,000.00 | $81,000.00 |
| Revenue This Year | $7.43 | $554.81 |
| Revenue Next Year | $6.25 | $517.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 46.25 | 5.19 |
| 52 Week Low | $5.78 | $1.37 |
| 52 Week High | $16.92 | $4.09 |
| Indicator | SSTI | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 58.25 |
| Support Level | $6.16 | $1.67 |
| Resistance Level | $7.04 | $2.41 |
| Average True Range (ATR) | 0.40 | 0.23 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 60.81 | 76.88 |
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes: ShotSpotter, the acoustic gunshot detection system; CrimeTracer, the foremost law enforcement search engine; CaseBuilder, a one-stop investigation management system; ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact; PlateRangerTM powered by Rekor, an automatic license plate recognition ("ALPR") and vehicle identification solution; SafePointe, an AI-based weapons detection system.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.